Drug intelligence / Profile preview

zhikang capsule

Development stage
Phase 4
Lead developer
Xi'an Qianhe Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Zhikang Capsule (ZKC) is a traditional Chinese medicine (TCM) formulation composed of 14 herbal ingredients, including Rhubarb, Coptis chinensis, pseudo-ginseng, and radix among others[4]. It is modified from classic TCM formulas Qi-Li-San and Fu-Jin-Sheng-Ji-San. ZKC has been widely used in China for the treatment of inflammatory bowel diseases (IBD), traumatic bleeding, uterine bleeding, hematemesis, hematochezia, posttraumatic swelling and pain[1][2]. Mechanistically, ZKC exhibits anti-inflammatory effects by inhibiting pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6; suppressing COX-2 and iNOS expression; reducing oxidative stress; promoting M2 macrophage polarization; inhibiting apoptosis via downregulation of caspase-3; modulating the MyD88-dependent TLR4 signaling pathway; and weakening NF-κB signaling[1][3][4]. It also demonstrates potential anti-tumor activity by inhibiting proliferation and inducing apoptosis in breast cancer cells[4], as well as improving hemorheology indices to prevent thrombus formation in trauma patients[5].

Brand names
Zhikang Capsule
Other names
ZKCZhikang capsule
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)CASP3 (Caspase-3)IL1B (Interleukin-1 beta)IL-6 (Interleukin 6)NF-κBTNFA (Tumor necrosis factor alpha (soluble))NOS2 (Nitric Oxide Synthase 2)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on zhikang capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zhikang capsule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call